Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 5:06 pm Unchanged | 2024-12-31 | 13G | Protagenic Therapeutics, Inc. PTIX | Armistice Capital, LLC | 17,143 3.410% | 0 (Unchanged) | Filing History |
| 2024-11-14 5:19 pm Unchanged | 2024-09-30 | 13G | Protagenic Therapeutics, Inc. PTIX | Armistice Capital, LLC | 17,143 5.100% | 0 (Unchanged) | Filing History |
| 2024-02-14 2:29 pm Purchase | 2023-12-31 | 13G | Protagenic Therapeutics, Inc. PTIX | Armistice Capital, LLC | 17,143 5.130% | 17,143 (New Position) | Filing History |
| 2023-02-14 1:17 pm Unchanged | 2022-12-31 | 13G | Protagenic Therapeutics, Inc. PTIX | Armistice Capital, LLC | 17,143 5.260% | 0 (Unchanged) | Filing History |
| 2022-02-14 6:19 pm Purchase | 2021-12-31 | 13G | Protagenic Therapeutics, Inc. PTIX | Armistice Capital, LLC | 17,143 5.400% | 17,143 (New Position) | Filing History |
| 2022-02-04 4:29 pm Sale | 2021-12-31 | 13G | Protagenic Therapeutics, Inc. PTIX | Hudson Bay Capital Management LP | 0 0.000% | -19,517 (Position Closed) | Filing History |
| 2021-02-10 3:43 pm Purchase | 2020-12-31 | 13G | Protagenic Therapeutics, Inc. PTIX | Hudson Bay Capital Management LP | 19,517 9.990% | 196 (+1.02%) | Filing History |